KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Treasury Shares: 2009-2024

Historic Treasury Shares for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $5.3 billion.

  • Idexx Laboratories' Treasury Shares rose 24.27% to $6.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 billion, marking a year-over-year increase of 24.27%. This contributed to the annual value of $5.3 billion for FY2024, which is 19.20% up from last year.
  • Latest data reveals that Idexx Laboratories reported Treasury Shares of $5.3 billion as of FY2024, which was up 19.20% from $4.5 billion recorded in FY2023.
  • Idexx Laboratories' 5-year Treasury Shares high stood at $26.2 million for FY2024, and its period low was $779,000 during FY2020.
  • Moreover, its 3-year median value for Treasury Shares was $24.5 million (2023), whereas its average is $17.6 million.
  • Data for Idexx Laboratories' Treasury Shares shows a peak YoY climbed of 27.53% (in 2021) over the last 5 years.
  • Idexx Laboratories' Treasury Shares (Yearly) stood at $2.8 billion in 2020, then grew by 27.53% to $3.6 billion in 2021, then increased by 23.00% to $4.4 billion in 2022, then grew by 1.88% to $4.5 billion in 2023, then grew by 19.20% to $5.3 billion in 2024.